2D and 3D Echocardiography in the Axolotl (Ambystoma Mexicanum)
November 29th, 2018
15K views
Here we present echocardiography protocols for two-dimensional and three-dimensional image acquisition of the beating heart of the axolotl salamander (Ambystoma mexicanum), a model species in heart regeneration. These methods allow for longitudinal evaluation of cardiac function at a high spatiotemporal resolution.
Overview
This article presents echocardiography protocols for acquiring two-dimensional and three-dimensional images of the axolotl salamander's beating heart. These methods facilitate high-resolution, noninvasive evaluations of cardiac function, crucial for studying heart regeneration.
Key Study Components
Area of Science
- Neuroscience
- Cardiac regeneration
- Amphibian biology
Background
- The axolotl salamander is a model organism for studying heart regeneration.
- Understanding cardiac regeneration can provide insights into regenerative medicine.
- High-resolution imaging techniques are essential for evaluating cardiac function.
- This method can also be applied to other amphibians like newts and xenopus.
Purpose of Study
- To develop protocols for echocardiography in axolotls.
- To enable longitudinal studies of cardiac function.
- To assess the progression of cardiac regeneration after injury.
Methods Used
- Positioning the axolotl supine in a specialized animal bed.
- Securing the animal with rubber bands to prevent floating.
- Filling the bed with anesthetic medium to a specific depth.
- Utilizing echocardiography for image acquisition.
Main Results
- Successful acquisition of high-resolution images of the axolotl heart.
- Demonstrated the feasibility of longitudinal cardiac function evaluation.
- Provided a noninvasive method for assessing cardiac regeneration.
- Potential for application in other amphibian species.
Conclusions
- The developed echocardiography protocols are effective for axolotls.
- This technique offers a valuable tool for regenerative research.
- Future studies can leverage this method to explore cardiac regeneration mechanisms.
Frequently Asked Questions
What is the significance of using axolotls in cardiac research?
Axolotls are known for their remarkable regenerative abilities, making them ideal for studying heart regeneration.
How does echocardiography benefit cardiac function assessment?
Echocardiography provides high-resolution, noninvasive imaging, allowing for detailed evaluation of cardiac function over time.
Can this method be applied to other species?
Yes, the protocols can also be adapted for use in other amphibians such as newts and xenopus.
What are the main advantages of this technique?
The main advantages include high resolution, noninvasiveness, and the ability to conduct repeat evaluations.
What are the steps involved in preparing the axolotl for imaging?
The axolotl is positioned supine, secured, and placed in a medium containing anesthetics to facilitate imaging.
How does this research contribute to regenerative medicine?
It provides insights into the mechanisms of cardiac regeneration, which can inform therapeutic strategies for heart injuries in humans.
Executive Industry Relevance
Noninvasive, repeatable cardiac function assessment in regenerative models supports early-stage target validation and mechanistic de-risking in cardiovascular therapeutic development. High-resolution echocardiography enables quantitative phenotypic screening and longitudinal monitoring of regeneration outcomes, improving predictive confidence in preclinical candidates. This approach addresses the discovery-stage challenge of translating mechanistic findings into translatable biomarkers for heart failure and ischemic injury models.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by quantifying cardiac function changes following myocardial injury in a regenerative model.
- Operational Value: Provides reproducible, anesthesia-compatible workflow for longitudinal assessment of regeneration progression.
- Predictive Value: Supports target confidence through functional readouts that correlate with structural recovery and pathway modulation.
Screening & Assay Development
- Scientific Value: Generates quantitative dependent variable measurements (ejection fraction, ventricular dimensions, flow velocity) for compound screening in amphibian models.
- Operational Value: Standardizes image acquisition via intra/inter-operator analysis to minimize measurement bias and ensure assay reproducibility.
- Scalability: Enables preparation of validated biological systems for downstream compound evaluation and target engagement studies.
Translational & Preclinical Research
- Translational Continuity: Connects discovery-phase regeneration metrics to preclinical validation through disease-relevant system modeling in axolotl.
- Mechanistic De-risking: Facilitates assessment of flow dynamics and chamber-specific function to de-risk targets involved in contractility and vascular integration.
- Biomarker Alignment: Supports identification of functional biomarkers tied to regeneration stages, enabling risk-adjusted advancement decisions.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target validation through lead identification to preclinical assessment by providing functional cardiac readouts that inform go/no-go decisions.
- Discovery Biology: Supports hypothesis testing and pathway clarification via serial monitoring of cardiac regeneration after injury.
- Screening: Delivers assay readiness through standardized 2D and 3D acquisition protocols with quantitative Doppler-derived outputs.
- Analytics: Enables comparison of conditions via velocity-time integrals, chamber volumes, and wall motion metrics for phenotypic screening.
- Translational Research: Connects to preclinical continuity by modeling human-relevant cardiac structure and flow dynamics in a regenerative context.
- Enterprise Reuse: Establishes a reusable imaging capability across amphibian models (newt, xenopus) for cross-platform validation.
Operational & Enterprise Impact
- Scientific Value: Reduction of mechanistic ambiguity through direct visualization of blood-tissue contrast and chamber-specific regeneration.
- Operational Value: Standardization and reproducibility via transducer positioning protocols and inter-observer analysis to minimize subjectivity.
- Strategic Value: Improved go/no-go decisions by linking functional recovery to molecular interventions, reducing late-stage biological risk.
- Portfolio Impact: Risk-adjusted prioritization based on quantitative cardiac function thresholds and regeneration kinetics.
Implementation Considerations
- Required expertise in ultrasound transducer handling and amphibian anesthesia protocols (benzocaine, MS-222, propofol).
- Instrumentation needs include 40–50 Hz transducers, B-mode, color-Doppler, power-Doppler, and pulse-wave Doppler capabilities.
- Cross-team standardization requires training on ventricular long-axis, short-axis, and atrial view acquisition for consistent measurements.
- Adaptation considerations across model systems involve adjusting transducer frequency and medium depth based on animal size and pigmentation.
- Practical limitations include motion sensitivity during 3D acquisition requiring anesthesia and prolonged scan times up to one hour per animal.
Biopharma FAQs
Why does inter-operator analysis matter for target validation assays?
Inter-operator analysis minimizes measurement subjectivity in 2D echocardiography, ensuring reproducible quantification of cardiac function across users. This reproducibility is essential for reliable target validation assays where small functional changes must be detected with confidence.
How does isolating the ventricular long-axis view support discovery pipeline workflows?
Isolating the ventricular long-axis view enables accurate measurement of end-systole cross-sectional area, a key functional readout for contractility assessment. This standardized view supports hypothesis testing in discovery pipelines by providing a consistent anatomical plane for longitudinal tracking.
What quantitative dependent variable measurements enable phenotypic screening in regeneration studies?
Velocity-time integrals from pulse-wave Doppler, ventricular dimensions, and atrial volume measurements provide quantitative endpoints for screening regenerative compounds. These metrics allow comparison of cardiac function pre- and post-injury across treatment groups.
Why do replication requirements matter for cross-functional collaboration in echocardiography?
Replication of at least three cardiac cycles per view ensures data robustness and minimizes variability from transient physiological states. This standard enables cross-functional teams to compare results with confidence in target validation and lead optimization efforts.
What statistical analysis capabilities are required before implementing 3D echocardiography workflows?
Angular correction and beam angle adjustment (up to 45 degrees) are required to align outflow tract flow with the transducer for accurate velocity measurements. These corrections ensure reliable Doppler-derived data for downstream statistical analysis of flow dynamics and cardiac output.
